New Avandia Setback? Possible Second Black Box Warning on Heart Attack
The Food and Drug Administration would like to include the strongest safety
warning about heart attack risk to Avandia's label, reported the Wall Street
Journal on October 24, 2007.
This new addition would be the second
so-called "black-box warning" to be added to the Avandia label. The first one
carries a warning about heart failure--another side effect of the dangerous Type
2 diabetes drug.
The FDA is reportedly still in discussions with
GlaxoSmithKline about adding the warning.
An FDA analysis found that
Avandia seems to be linked to a 38 percent higher risk of events in which blood
is choked off from the heart in users.
If you or a loved one has suffered
cardiac complications after ingesting Avandia, you deserve the guidance of a
knowledgeable drug attorney. Get a free case review by filling out the form
below.
see also:
Avandia Problems
Glaxo Failed to Alert FDA about Avandia Studies That Revealed ProblemsFDA sends letter to Glaxo on failure to inform of Avandia's problems
Avandia Diabetes Pills
Glaxo Failed to Disclose Studies Regarding Avandia Diabetes PillsFDA wasn't told about safety reports on Avandia Pills--lawsuit info
News & Warnings
Avandia Breaking News: Glaxo Warned in 2001 about Misleading MarketingBloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001


